Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of lenvatinib and everolimus in unresectable advanced or metastatic non-clear cell renal cell carcinoma (nccRCC) shows …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-clear Cell Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Non Clear Cell Renal Cell Carcinoma (nccRCC) | Phase 2 | Status: COMPLETED | Results posted: 2020-07-13